Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


DHgate

Home > Press > Acrongenomics, Inc. Retains KGMC Group, LLC

Acrongenomics, Inc. Retains KGMC Group, LLC

Posted on November 09, 2005

Acrongenomics, Inc. (OTCBB:AGNM - News) is pleased to announce that it has retained KGMC Group, LLC of Frankfort, Illinois to introduce its cutting-edge Nano-JETA(TM) technology platform to the world market.

Privately-held KGMC Group LLC introduces and markets advanced medical technologies. With a diverse team of talented and respected professionals in medicine, science, business, finance, marketing and law from four continents, KGMC provides services and solutions essential to converting emerging technologies into viable business ventures. KGMC Group LLC will work with Acrongenomics to complete formal validations of the advanced Nano-JETA(TM) platform, secure publications of this breakthrough technology in respected medical and scientific journals and identify ideal partners to commercialize the technology.

"Following a year of thorough study, our scientists and Board of Directors have confirmed that Acrongenomics' know-how in nanotechnology has resulted in compelling breakthroughs, significantly impacting our battle with various diseases such as cancer. We are convinced that Nano-JETA(TM) technology platform can accelerate and enhance the commonly used Real Time PCR amplification process, so that it is rendered 100% accurate in detecting genetic diseases such as cancer.

Neo-EpCAM(TM) cancer detection assay is the first application utilizing the Nano-JETA(TM) technology. More so exciting is that the process takes less than two minutes. Because it is fast, inexpensive, easy to administer, non-invasive, accurate, specific and uses existing equipment, we are convinced that the technology will assist physicians in detecting genetic diseases quickly, accurately and early enough to potentially save lives and avoid much cost and anguish. Now confident in the technology, we will assist Acrongenomics in securing a partner to further develop and market such technology," Says KGMC Group President Bill Kanatas.

####

About Acrongenomics Inc.:
Acrongenomics Inc. (OTCBB:AGNM - News) is a publicly traded research and development nanobiotechnology company pioneering the development of uniquely advanced nano-molecular diagnostics for the Life Sciences Industry. The Company is seeking to establish its proprietary nanotechnology platform as a global standard in Molecular In Vitro Diagnostics.

Acrongenomics has successfully conducted laboratory tests and clinical trials for the cancer detection and quantification process. The technology has been applied to major Molecular Diagnostics techniques such as Polymerase Chain Reaction (PCR) and Real-Time PCR producing outstanding results in terms of sensitivity, reproducibility, specificity and speed with the use of conventional equipment.

Since the completion of the Human Genome project in 2000, the growing number of sequencing and functional genomic initiatives has resulted in the rapid growth of the Molecular Diagnostics field. In 2005, the global market for molecular diagnostics is estimated to reach $6.5 billion. By 2010 the market is forecasted to expand to $12 billion and to $35 billion by 2015 (Research & Markets Report 2004). There is considerable demand for new molecular diagnostic technologies. So profitable is the molecular diagnostics market that pharmaceutical and biotechnology companies are highly focused in developing molecular diagnostics tests that can be used to individualize patient treatments.

With the validation and introduction of the Nano-JETA(TM) technology platform, along with the support of KGMC Group LLC, Acrongenomics is positioned to emerge as a leader in this rapidly expanding market segment.

For more information, please click here

Contact:
Acrongenomics Inc.
Investor Relations
1-800-689-8181
email: ir@acrongen.com

Copyright © Acrongenomics Inc.

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Efficiency of Nanodrug Containing Antibiotics in Treatment of Infectious Diseases Evaluated August 31st, 2015

Researchers use DNA 'clews' to shuttle CRISPR-Cas9 gene-editing tool into cells August 30th, 2015

Iranian Scientists Use Artemisia Annua Plant to Produce Breast Cancer Drugs August 29th, 2015

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

Announcements

Nanotech could rid cattle of ticks, with less collateral damage September 1st, 2015

Scientists 'squeeze' light one particle at a time: A team of scientists have measured a bizarre effect in quantum physics, in which individual particles of light are said to have been 'squeezed' -- an achievement which at least one textbook had written off as hopeless September 1st, 2015

An engineered surface unsticks sticky water droplets August 31st, 2015

New material science research may advance tech tools August 31st, 2015

Tools

Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World: Nanolab Orders Advanced Local Electrode Atom Probe (LEAP®) Microscope from CAMECA Unit of AMETEK Materials Analysis Division August 27th, 2015

Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015

50 Years of Scanning Electron Microscopy from ZEISS: ZEISS celebrates the birth of the first commercial scanning electron microscope in 1965 August 26th, 2015

Announcing Oxford Instruments and School of Physics signing a Memorandum of Understanding August 26th, 2015

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







Car Brands
Buy website traffic